cholinergic therapeutics (Ophidion)

N/A

Report date: 2025/03/14 16:44:35
NME

Base Information

Drug Namecholinergic therapeutics (Ophidion)
Drug Alias NamesiRNA mediated lynx-1 modulators (Ophidion)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionNicotinic receptors modulators
TargetsNicotinic receptors
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOphidion Inc
China Registration ClassN/A

Develop Information

Active CompaniesOphidion Inc
Inactive CompaniesN/A
Active IndicationsCognition Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A